Phase 1 HER-2 Protein Overexpression Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

Soft Tissue SarcomaSarcomaOsteosarcoma+5 more

Baylor College of Medicine25 enrolled1 locationNCT04995003

Recruiting

Phase 1

PRE-I-SPY Phase I/Ib Oncology Platform Program

Metastatic Breast CancerHER2-negative Breast CancerMetastatic Cancer+5 more

QuantumLeap Healthcare Collaborative124 enrolled7 locationsNCT05868226